Home » UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency

UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency

This post was originally published on this site.

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.